The Technical Analyst
MedTech Acquisition [MTACU]
Exchange: NASDAQ Capital Market Sector: Financial Services Industry: Shell Companies
MedTech Acquisition Price, Forecast, Insider, Ratings, Fundamentals & Signals
12.94% $11.35
/ 10 aug 2023 @ 15:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 84.29 mill |
| EPS: | 0.255 |
| P/E: | 44.51 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 7.43 mill |
| Avg Daily Volume: | 0.0001 mill |
| RATING 2023-08-10 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | |||||
| Gr.Profit | n/a | |||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 44.51 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 44.51 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 11.33 - 11.37 ( +/- 0.19%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-08-30 | Devlin Jodi | Buy | 195 000 | Employee Stock Option (right to buy) |
| 2023-08-28 | Devlin Jodi | Buy | 0 | |
| 2023-08-14 | Szela Mary T | Buy | 172 500 | Employee Stock Option (right to buy) |
| 2023-08-10 | Szela Mary T | Sell | 0 | Common Stock |
| 2023-08-10 | Szela Mary T | Sell | 55 616 | Employee Stock Option (right to buy) |
| INSIDER POWER |
|---|
| 10.07 |
| Last 69 transactions |
| Buy: 9 379 921 | Sell: 14 592 900 |
Forecast:
01:40 - $10.22
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $11.35 (12.94% ) |
| Volume | 0.0020 mill |
| Avg. Vol. | 0.0001 mill |
| % of Avg. Vol | 2 101.06 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MTACU
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MTACU
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.
Latest Press Releases
2021-02-05 16:05:00 - Press Release
Medtech Acquisition Corporation Announces Separate Trading Of Its Class A Common Stock And Warrants, Commencing February 8, 2021
New york, ny, feb. 05, 2021 (globe newswire) -- medtech acquisition corporation (nasdaq:mtacu) (the “company”) announced today that, commencing february 8, 2021, holders of the 25,000,000 units sold in the company's initial public offering may elect to separately trade shares of the company's class a common stock and warrants included in the units. the shares of class a common stock and warrants that are separated will trade on the nasdaq capital market (“nasdaq”) under the symbols “mtac” and “mtacw”, respectively. no fractional warrants will be issued upon separation of the units and only whole warrants will trade. those units not separated will continue to trade on nasdaq under the symbol “mtacu...
2020-12-22 17:12:00 - Press Release
Medtech Acquisition Corporation Announces Closing Of Upsized $250,000,000 Initial Public Offering
New york, ny, dec. 22, 2020 (globe newswire) -- medtech acquisition corporation (the “company”) announced today that it closed its initial public offering of 25,000,000 units, which included 3,000,000 units pursuant to the partial exercise of the underwriters' over-allotment option. the offering was priced at $10.00 per unit, resulting in gross proceeds of $250,000,000.
Latest News
2023-07-27 20:32:55 - GuruFocus
Magnetar Financial LLC Reduces Stake in MedTech Acquisition Corp
On July 25, 2023, Magnetar Financial LLC (Trades, Portfolio), a renowned investment firm, reduced its stake in MedTech Acquisition Corp ( MTACU , Financial). This article provides an in-depth analysis of the transaction, the profiles of both the firm and the traded company, and the potential implications for value investors.
2021-02-05 16:05:00 - GlobeNewsWire
MedTech Acquisition Corporation Announces Separate Trading of its Class A Common Stock and Warrants, Commencing February 8, 2021
New York, NY, Feb. 05, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq:MTACU) (the “Company”) announced today that, commencing February 8, 2021, holders of the 25,000,000 units sold in the Company's initial public offering may elect to separately trade shares of the Company's Class A common stock and warrants included in the units. The shares of Class A common stock and warrants that are separated will trade on The Nasdaq Capital Market (“Nasdaq”) under the symbols “MTAC” and “MTACW”, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on Nasdaq under the symbol “MTACU...
2020-12-22 17:12:00 - GlobeNewsWire
MedTech Acquisition Corporation Announces Closing of Upsized $250,000,000 Initial Public Offering
New York, NY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (the “Company”) announced today that it closed its initial public offering of 25,000,000 units, which included 3,000,000 units pursuant to the partial exercise of the underwriters' over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $250,000,000.